← FDA Drug Approvals (Drugs@FDA)
ULTRAGRIS-165
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PLIVA · Approved 1992-06-30
Drug application
- FDA Application #
ANDA062645- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ULTRAGRIS-165
- Generic name
- Griseofulvin, Ultramicrocrystalline
- Active ingredients
- GRISEOFULVIN, ULTRAMICROCRYSTALLINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- PLIVA
- First approval
- 1992-06-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown